M. Degardin

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

Jean Louis Lefèbvre, Y. Pointreau, Frédéric Rolland et al. · Journal of Clinical Oncology · 2013 · 418 citations · Full text

Medicine, Oncology, Otolaryngology +16

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Tanguy Y. Seiwert, Jérôme Fayette, Didier Cupissol et al. · Annals of Oncology · 2014 · 182 citations · Full text

Medicine, Oncology, Pharmacology +17

Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer

Éric Lartigau, Emmanuelle Tresch, Juliette Thariat et al. · Radiotherapy and Oncology · 2013 · 181 citations

Medicine, Oncology, Radiation Oncology +7

Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer

M. Degardin, Jacques Bonneterre, B Hecquet et al. · Annals of Oncology · 1994 · 147 citations

Medicine, Oncology, Pharmacology +16